» Articles » PMID: 33114170

Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer's Disease

Overview
Journal Cells
Publisher MDPI
Date 2020 Oct 29
PMID 33114170
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

A new epoch is emerging with intense research on nutraceuticals, i.e., "food or food product that provides medical or health benefits including the prevention and treatment of diseases", such as Alzheimer's disease. Nutraceuticals act at different biochemical and metabolic levels and much evidence shows their neuroprotective effects; in particular, they are able to provide protection against mitochondrial damage, oxidative stress, toxicity of β-amyloid and Tau and cell death. They have been shown to influence the composition of the intestinal microbiota significantly contributing to the discovery that differential microorganisms composition is associated with the formation and aggregation of cerebral toxic proteins. Further, the routes of interaction between epigenetic mechanisms and the microbiota-gut-brain axis have been elucidated, thus establishing a modulatory role of diet-induced epigenetic changes of gut microbiota in shaping the brain. This review examines recent scientific literature addressing the beneficial effects of some natural products for which mechanistic evidence to prevent or slowdown AD are available. Even if the road is still long, the results are already exceptional.

Citing Articles

Kaempferia parviflora extract and its methoxyflavones as potential anti-Alzheimer assessing in vitro, integrated computational approach, and in vivo impact on behaviour in scopolamine-induced amnesic mice.

Takomthong P, Waiwut P, Yenjai C, Wangboonskul J, Plekratoke K, Arsito P PLoS One. 2025; 20(3):e0316888.

PMID: 40063637 PMC: 11892870. DOI: 10.1371/journal.pone.0316888.


Dietary Strategies to Mitigate Alzheimer's Disease: Insights into Antioxidant Vitamin Intake and Supplementation with Microbiota-Gut-Brain Axis Cross-Talk.

Wan Ngah W, Ahmad H, Ankasha S, Makpol S, Tooyama I Antioxidants (Basel). 2025; 13(12.

PMID: 39765832 PMC: 11673287. DOI: 10.3390/antiox13121504.


Zeaxanthin and Lutein Ameliorate Alzheimer's Disease-like Pathology: Modulation of Insulin Resistance, Neuroinflammation, and Acetylcholinesterase Activity in an Amyloid-β Rat Model.

Kim D, Kang S, Moon N, Shin B, Park S Int J Mol Sci. 2024; 25(18).

PMID: 39337316 PMC: 11432044. DOI: 10.3390/ijms25189828.


Exploring the therapeutic potential of leaf extract against amyloid-beta-induced toxicity in the model of Alzheimer's disease.

Wen Y, Fu H, Chen Q, Lan C, Qin D, Wu J Front Pharmacol. 2024; 15:1408031.

PMID: 38983916 PMC: 11232431. DOI: 10.3389/fphar.2024.1408031.


Research Progress of Bioactive Components in spp.

Lu J, Su M, Zhou X, Li D, Niu X, Wang Y Molecules. 2024; 29(6).

PMID: 38542832 PMC: 10976032. DOI: 10.3390/molecules29061195.


References
1.
Shukitt-Hale B . Blueberries and neuronal aging. Gerontology. 2012; 58(6):518-23. DOI: 10.1159/000341101. View

2.
Rodriguez R, Albeck J, Taha A, Ori-McKenney K, Recanzone G, Stradleigh T . Impact of diet-derived signaling molecules on human cognition: exploring the food-brain axis. NPJ Sci Food. 2019; 1:2. PMC: 6548416. DOI: 10.1038/s41538-017-0002-4. View

3.
Vogt N, Kerby R, Dill-McFarland K, Harding S, Merluzzi A, Johnson S . Gut microbiome alterations in Alzheimer's disease. Sci Rep. 2017; 7(1):13537. PMC: 5648830. DOI: 10.1038/s41598-017-13601-y. View

4.
Cole J, Marioni R, Harris S, Deary I . Brain age and other bodily 'ages': implications for neuropsychiatry. Mol Psychiatry. 2018; 24(2):266-281. PMC: 6344374. DOI: 10.1038/s41380-018-0098-1. View

5.
Prakash A, Kumar A . Implicating the role of lycopene in restoration of mitochondrial enzymes and BDNF levels in β-amyloid induced Alzheimer׳s disease. Eur J Pharmacol. 2014; 741:104-11. DOI: 10.1016/j.ejphar.2014.07.036. View